Nutriband Inc.
USD1.00
+0.23 (+29.87%)
CEO
Gareth Sheridan
IPO Date
2021-10-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.61
Prev. Close
$0.77
Day Low
$1.00
Day High
$2.61
52W Low
$0.77
52W High
$4.50
Market Cap
$0.05B
Volume
0.00M
| -8.4 |
| 31 Jan 2024 | FY | 41.3% | -263.0% | -85.2% | -73.0% | 0.04 | 1.02 | -3.8 |
| 31 Jan 2023 | FY | 36.1% | -231.3% | -56.1% | -50.9% | 0.02 | 3.60 | -6.4 |
| 31 Jan 2022 | FY | 35.5% | -592.2% | -71.0% | -66.1% | 0.01 | 7.01 | -3.5 |
| 31 Jan 2021 | FY | 38.3% | -340.5% | -45.2% | -32.4% | 0.25 | 0.12 | -12.0 |
| 31 Jan 2020 | FY | -48.1% | -754.1% | -1593.2% | -127.2% | 1.83 | 0.02 | -13.0 |
| 31 Jan 2019 | FY | -17.5% | -1358.1% | -138.5% | -118.7% | 0.02 | 1.47 | -10.8 |
| 31 Jan 2018 | FY | 0.0% | 0.0% | -2199.0% | -1620.4% | 0.26 | 3.80 | -12.0 |
| 31 Jan 2017 | FY | 0.0% | 0.0% | -654.6% | -400.9% | 0.45 | 2.58 | -229.9 |
| -5.2 |
| 31 Jul 2025 | Q2 | 23.9% | -321.4% | -23.6% | -19.7% | 0.03 | 4.78 | -10.1 |
| 30 Apr 2025 | Q1 | 34.2% | -208.1% | -27.2% | -22.6% | 0.06 | 3.71 | -13.8 |
| 31 Jan 2025 | Q4 | 42.8% | -858.7% | -85.8% | -73.8% | 0.03 | 4.88 | -4.0 |
| 31 Oct 2024 | Q3 | 27.8% | -211.1% | -12.1% | -10.9% | 0.02 | 4.96 | -12.6 |
| 31 Jul 2024 | Q2 | 20.5% | -385.0% | -13.7% | -12.5% | 0.02 | 6.57 | -9.7 |
| 30 Apr 2024 | Q1 | 37.7% | -464.6% | -14.2% | -12.5% | 0.04 | 6.16 | -4.2 |
| 31 Jan 2024 | Q4 | 32.4% | -358.5% | -29.2% | -25.0% | 0.04 | 1.02 | -2.8 |
| 31 Oct 2023 | Q3 | 37.1% | -411.4% | -30.8% | -20.6% | 0.40 | 2.79 | -2.5 |